ANXA1 and uveitis: Beyond, Annexin A1 and its fragment Ac2-26 have demonstrated positive effects in various preclinical models of pathological conditions, such as multiple sclerosis, pneumococcal pneumonia, arthritis, uveitis, and wound healing [19,20,21].